AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
1min snip
23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health tech
Crucible Moments
Long Roads Lead to Meaningful Progress
23andMe is advancing its mission with the development of 23me 16, an investigational cancer drug that is currently entering phase two of testing. Phase one confirmed the safety and tolerability of the drug, while phase two will assess its effectiveness in treating advanced cancers. Although there's still a long journey ahead to validate its efficacy, the commitment to tackling complex challenges allows the company to recognize and appreciate the strides made in addressing significant health issues.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode